Morbidity of the Abdominal Wall Resection and Reconstruction After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

被引:0
|
作者
Maria F. Nunez
Armando Sardi
Carol Nieroda
William Jimenez
Michelle Sittig
Ryan MacDonald
Nail Aydin
Vladimir Milovanov
Vadim Gushchin
机构
[1] Institute for Cancer Care at Mercy Medical Center,
来源
关键词
Peritoneal Carcinomatosis; Wound Complication; Port Site; Peritoneal Cancer Index; Complete Cytoreduction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1658 / 1663
页数:5
相关论文
共 50 条
  • [21] Cytoreductive Reductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Ovarian Cancer
    Tan, G.
    Chia, C.
    Teo, M.
    Soo, K. C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 839 - 839
  • [22] Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Emmanuel Gabriel
    Enrique Elli
    Sanjay Bagaria
    Nabil Wasif
    Travis Grotz
    John Stauffer
    Pashtoon M. Kasi
    Horacio Asbun
    Journal of Robotic Surgery, 2019, 13 : 175 - 179
  • [23] Extended Survival in the Elderly Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)
    Shankar, S.
    Sittig, M.
    Nieroda, C.
    MacDonald, R.
    Gushchin, V.
    Sardi, A.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S103 - S103
  • [24] Water lavage as an adjunct to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
    Gabriel, Emmanuel
    Singla, Smit
    Kim, Minhyung
    Fisher, Daniel
    Powers, Colin
    Visioni, Anthony
    Attwood, Kristopher
    Skitzki, Joseph
    AMERICAN JOURNAL OF SURGERY, 2017, 214 (03): : 462 - 467
  • [25] ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?
    Mangieri, Christopher W.
    Votanopoulos, Konstantinos I.
    Shen, Perry
    Levine, Edward A.
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3694 - 3694
  • [26] Implementation of a Multidisciplinary Enhanced Recovery After Surgery (ERAS) Program for Cytoreductive Surgery (CRS) With Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Stockley, Cecily
    Bouchard-Fortier, Antoine
    Mateshaytis, Jennifer
    Taqi, Kadhim
    Mack, Lloyd
    Nelson, Gregg
    Chong, Michael
    Deban, Melina
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [27] OUTCOMES OF CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN THE TREATMENT OF PRIMARY PERITONEAL CARCINOMA
    Sardi, A.
    Diaz-Montes, T.
    Sipok, A.
    Sittig, M.
    Nieroda, C.
    Gushchin, V.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 679 - 679
  • [28] Peritoneal Carcinomatosis in the Elderly: Too Old for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/ HIPEC)?
    Yudegarynia, Sina
    Hernandez, Alexandra
    Montealegre, Mariaugusta
    Cash, Charles
    Gomez, Kimberly P.
    Joshi, Priyashma
    Noe, Daniel G.
    Bahna, Heidi
    Moller, Mecker
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S233 - S233
  • [29] Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria
    Pamela, Kogler
    Matthias, Zitt
    Reinhold, Kafka-Ritsch
    Julia, Punter
    Peter, Muessigang
    Alexander, Perathoner
    Dietmar, Oefner
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (05) : 884 - 893
  • [30] Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
    Gaillard, M.
    Van Eyken, P.
    Verswijvel, G.
    van der Speeten, K.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (SUPPL 1) : 240 - 249